Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies

Shouheng Lin(Chinese Academy of Sciences), Xiaofang Sun(Third Affiliated Hospital of Guangzhou Medical University)
Frontiers in Immunology
April 2, 2021
Cited by 24


Related Papers